Article
Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective study
2025-01-06
Abstract excerpt
<title>Abstract</title> <p>Purpose This study evaluated pharmacogenomic (PGx) testing in children and adolescents with autism spectrum disorder (ASD). ASD frequently presents with co-occurring depression and anxiety. This complex phenotype often results in psychotropic medication polypharmacy. Incorporating PGx testing into the medical work-up may reduce polypharmacy and improve quality of life with symptom redu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9ce25901-ccc2-5564-9688-ad872600982e
- DOI
- 10.21203/rs.3.rs-5753717/v1
